Products Documents
Technical Resources > Reading Room > TechNotes > Volume 12:3
TechNotes 12(3)  

RNA Interference
Complete Toolkit for Transfection Optimization

• New Silencer® CellReady™ siRNA Transfection Optimization Kit
• New KDalert™ GAPDH Assay Kit
Silencer Positive and Negative Control siRNAs
Silencer siRNA Transfection II Kit

Optimizing siRNA delivery and cell viability during transfection assays eliminates the most common causes of unsuccessful gene silencing experiments. Whether you will be screening a new Silencer CellReady siRNA Library (pre-plated siRNA ready for transfection) or one of the larger Silencer siRNA Libraries (1–5 nmol siRNAs), your experiments should start with optimization of transfection. Ambion now offers a comprehensive set of reagents to facilitate these experiments.

New! Silencer CellReady siRNA Transfection Optimization Kit

Before using the new Silencer CellReady Libraries, it is imperative to optimize transfection conditions for your cells in 96 well plates. This can be done with ease using the Silencer CellReady siRNA Transfection Optimization Kit. Developed specifically for transfection optimization of human cell lines using the same format as the CellReady Libraries, the Silencer CellReady siRNA Transfection Optimization Kit includes three 96 well plates containing positive (Silencer GAPDH siRNA) and negative (Silencer Negative Control #1 siRNA) control siRNAs, as well as 0.4 ml siPORT NeoFX and detailed instructions for determining optimal transfection parameters.

Silencer Transfection Kit II

In general, the first step when optimizing transfection conditions for a new cell type is to test siRNA delivery efficiency using different transfection agents and a positive and negative control siRNA. The Silencer Transfection Kit II is the ideal choice for optimizing siRNA transfection conditions in any size plate. This kit, which can be used with human, mouse, and rat cells, includes two different siRNA transfection agents—siPORT NeoFX and siPORT Amine—as well as the highly validated Silencer GAPDH siRNA and Silencer Negative Control #1 siRNA. siPORT Amine is a polyamine mixture, whereas siPORT NeoFX consists of a mixture of cationic and neutral lipids. These reagents support efficient, reproducible siRNA transfections in different cell types, and both have been validated for use with reverse transfection.

Silencer Positive and Negative Control siRNAs

If you have already identified a desired transfection agent, yet want to either fine tune transfection conditions or to monitor transfection in your experiments, consider one of the Silencer GAPDH siRNAs (see sidebar, Why Use GAPDH Control siRNAs?). Two GAPDH positive controls are fully validated for use in human cells, and one is also optimized for mouse and rat cells. Silencer Control siRNAs include 5 nmol of ready-to-use chemically synthesized GAPDH siRNA, and both include a separate negative control siRNA (2 nmol, Silencer Negative Control #1 siRNA).

Of course, every experiment requires a good negative control, and most experts agree that the best negative control is a non-targeting siRNA. Ambion offers three extensively tested and unique Negative Control siRNAs that have no significant sequence similarity to mouse, rat, or human gene sequences. Silencer Negative Controls include 5 nmol of ready-to-use chemically synthesized siRNA.

New! KDalert GAPDH Assay Kit

Ambion’s rapid fluorescence-based KDalert GAPDH Assay Kit accurately measures GAPDH enzymatic activity in cultured cells derived from human, mouse, and rat (for more details, see A New Way to Assess siRNA Delivery Efficiency), making it the perfect complement to the Silencer CellReady siRNA Transfection Optimization Kit, the Silencer siRNA Transfection II Kit, and the stand-alone Silencer GAPDH siRNA Controls. The assay was developed especially for cells transfected in 96 well plates, but is flexible enough for evaluation of transfection in other plate formats as well. The KDalert GAPDH Assay  Kit protocol is quicker and easier than traditional methods (e.g., Western blotting, quantitative RT-PCR) for measuring siRNA-induced knockdown, greatly accelerating transfection optimization experiments.

Optimal Conditions for Optimal Results

Investing the time to identify the best transfection conditions for your experimental system will limit transfection variability, and maximize data quality by maximizing siRNA uptake and minimizing cellular toxicity. This is especially important for 96 well format RNAi screening experiments, which require a fairly significant expenditure of time and reagents. Once you have identified an optimized transfection protocol, the interesting and productive work of siRNA library screening can begin!

back to top

Ordering Information for Ambion Products:

Cat# Product Name Size
AM1631 Silencer® siRNA Transfection II Kit 2 x 0.4 ml + Controls
AM1639 KDalert™ GAPDH Assay Kit 375 rxns
AM4605 Silencer® GAPDH siRNA (Human) 5 nmol + 2 nmol Neg Control (50 µM)
AM4611 Silencer® Negative Control #1 siRNA 5 nmol (50 µM)
AM4613 Silencer® Negative Control #2 siRNA 5 nmol (50 µM)
AM4615 Silencer® Negative Control #3 siRNA 5 nmol (50 µM)
AM4624 Silencer® GAPDH siRNA (Human, Mouse, Rat) 5 nmol + 2 nmol Neg Control (50 µM)
AM86050 Silencer® CellReady™ siRNA Transfection Optimization Kit 3 plates + 0.4 ml transfection agent
For Research Use Only. Not for use in diagnostic procedures.
TechNotes Archive
Ordering Information

Why Use GAPDH Control siRNAs?
The glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene is widely recognized as an ideal target for positive control siRNAs. GAPDH is expressed ubiquitously at fairly high levels in virtually all mammalian cells; this makes it extremely useful for evaluating both transfection efficiency and cell viability:

• Optimize transfection efficiency by transfecting a GAPDH positive control siRNA using experimental transfection agents and conditions to identify which provide the maximum knockdown of GAPDH activity.

• Optimize cell viability by transfecting a negative control siRNA to identify the transfection agent and conditions that do NOT cause knockdown of endogenous GAPDH activity and do not significantly decrease cell number compared to untransfected cells.

Related Links:
siRNA Delivery Resource
[read]


Optimizing siRNA Transfection for RNAi
[read]


A New Way to Assess siRNA Delivery Efficiency
[read]


High Throughput Delivery of siRNAs: Examples
[read]


 
Home | Products | Technical Resources | What's New | About Us | Contact Us
Advanced Search | Site Map | Privacy | Trademarks/Legal | Web Feedback | Jobs
© Applied Biosystems. All rights reserved.